Coronavirus Gilead has already priced in the united States
Andl remdesivir was already approved in the united States as a drug to treat the Covid-19. The company Gilead finally unveiled the cost of such treatment.
This medication will cost 54 thousand pesos, more than 2 thousand 340 dollars for people with health insurance in the American Union.
The treatment involves at least six doses, with a cost each of 390 dollars. While that will have a cost of 3 thousand 120 dollars with people with private insurance.
We announced the price today for our investigational antiviral for the treatment of COVID-19. We believe our unique approach will provide broad and equitable access. Read more from our Chairman & CEO: https://t.co/rrEbrDxrLk. pic.twitter.com/9ElSExqSU3
? Gilead Sciences (@GileadSciences) June 29, 2020
This price has been harshly criticized in the world. This for the high cost is not within the reach of any person. The company Gilead ensures that it has spent billion of dollars in the development and manufacturing of the drug.